Naturalistic Safety Registry Of Celecoxib (CELEBREX(R)) And NSAIDs In Juvenile Idiopathic Arthritis

Stopped early

Conditions studied: Arthritis, Juvenile Rheumatoid

In brief

This multi-center observational Registry will collect long-term safety data on patients treated with celecoxib or non-selective nonsteroidal anti-inflammatory drugs (nsNSAIDs) as used in clinical practice for the treatment of Juvenile Idiopathic Arthritis (JIA).

Key facts

Study ID

NCT00688545

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

275

Starts

2009-04-01

Expected to finish

2012-01-01

Last updated by the study team

2021-02-02

Who can join

Age: 2 and older, up to 17. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age at least 2 years but less than 18 years; JIA of any of the following subtypes: oligoarthritis, polyarthritis, or stable systemic disease;
• new treatment (started not more than 6 months prior) with one NSAID (celecoxib or nsNSAID).

You may not qualify if…

• Patients with the following JIA subtypes: active systemic disease, psoriatic Arthritis, enthesitis-related Arthritis, or undifferentiated arthritis;
• Patients with Reiter's syndrome; patients unlikely to complete 2 years of follow up;
• Patients who need to use multiple NSAIDs at the same time.

Where it is running

• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Little Rock, Arkansas, United States
• Pfizer Investigational Site — Washington D.C., District of Columbia, United States
• Pfizer Investigational Site — Arlington Heights, Illinois, United States
• Pfizer Investigational Site — Chicago, Illinois, United States
• Pfizer Investigational Site — Glenview, Illinois, United States
• Pfizer Investigational Site — New Lenox, Illinois, United States
• Pfizer Investigational Site — Westchester, Illinois, United States
• Pfizer Investigational Site — Omaha, Nebraska, United States
• Pfizer Investigational Site — Hackensack, New Jersey, United States
• Pfizer Investigational Site — Livingston, New Jersey, United States
• Pfizer Investigational Site — Brooklyn, New York, United States
• Pfizer Investigational Site — Brooklyn, New York, United States
• Pfizer Investigational Site — Commack, New York, United States
• Pfizer Investigational Site — Great Neck, New York, United States
• Pfizer Investigational Site — New Hyde Park, New York, United States
• Pfizer Investigational Site — New York, New York, United States
• Pfizer Investigational Site — Durham, North Carolina, United States
• Pfizer Investigational Site — Cincinnati, Ohio, United States
• Pfizer Investigational Site — Cleveland, Ohio, United States
• Pfizer Investigational Site — Liberty Township, Ohio, United States
• Pfizer Investigational Site — Mayfield Heights, Ohio, United States
• Pfizer Investigational Site — Strongsville, Ohio, United States
• Pfizer Investigational Site — Philadelphia, Pennsylvania, United States
• Pfizer Investigational Site — Charleston, South Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.